18 results
Thumbnail

D3.306 - Veno-Venous ECMO For Aprotinin-Induced Perioperative Anaphylaxis

Thumbnail

D3.308 - Kounis Syndrome: the allergic myocardial infarction

Thumbnail

D3.313 - Recurrent Anaphylaxis with Elevated Baseline Tryptase Revealing Hereditary Alpha-Tryptasemia with Mast Cell Activation

Thumbnail

D3.314 - Rapid desensitization to intravenous risankizumab after anaphylaxis in a patient with Crohn’s disease: a case report

Thumbnail

D3.315 - Management of Drug Hypersensitivity Reactions in an Oncology Patient: An Atypical Case of Omeprazole Allergy with Pantoprazole Tolerance

Thumbnail

D3.317 - Linguistic Validation of the Turkish Version of the Mastocytosis Control Test (MCT)

Thumbnail

D3.318 - Evaluation of Clinical Predictors and Serum Tryptase Levels in Systemic Mastocytosis

Thumbnail

D3.319 - Clinical Data of Drug Induced Anaphylaxis according to the standardized European Anaphylaxis Registry (NORA)

Thumbnail

D3.320 - Anaphylaxis by Chlorhexidine: A case series

Thumbnail

D3.321 - Cardiac arrest after Iodixanol: a case of non-IgE mediated mast cell activation

Thumbnail

D3.307 - Chlorhexidine-triggered anaphylaxis in a child with multisystem allergy and sickle cell disease: a diagnostic pitfall

Thumbnail

D3.309 - Basophil Activation Test Detects Rocuronium Allergy During the Post-Anaphylactic Refractory Period: A PAMA Case Report

Thumbnail

D3.322 - Successful management with Omalizumab and high-dose venom immunotherapy in a patient with Kounis Syndrome and Clonal Mast Cell Activation Syndrome

Thumbnail

- D3.545 - Natural Killer and Dendritic Cells Leverage Synergistic Interactions to Enhance Treatment of Non-Small Cell Lung Cancer

Thumbnail

- D3.544 - Allergic biomarkers and clinical outcomes in lung cancer patients treated with immune checkpoint inhibitors: a pilot study

Thumbnail

- D3.546 - AllergoOncology: Basophil number and subpopulation proportions may offer potential as predictive biomarkers in non-small cell lung cancer

Thumbnail

- D3.547 - Clinical Outcomes and Safety of Drug Desensitization in Chemotherapy-Induced Hypersensitivity

Thumbnail

- D3.548 - Refractory and persistent pruritus in an atopic patient: A red flag for underlying malignancy?